Cargando…

Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

AIM: This study was designed to investigate the predictive and prognostic values of serum vascular endothelial growth factor (VEGF) level in non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. METHODS: Patients’ peripheral blood samples were collected prior to chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Jialan, Hu, Yong, Xu, Xiaoyue, Ni, Jie, Yan, Dali, Liu, Siwen, He, Jieyu, Xue, Jing, Wu, Jianzhong, Feng, Jifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261848/ https://www.ncbi.nlm.nih.gov/pubmed/28176920 http://dx.doi.org/10.2147/OTT.S124124

Ejemplares similares

Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
por: Ma, Rong, et al.
Publicado: (2020)

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro
por: Hu, Yong, et al.
Publicado: (2017)

Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis
por: Varbanov, Hristo P., et al.
Publicado: (2019)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Wu, Le, et al.
Publicado: (2021)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy
por: Jin, Jianjun, et al.
Publicado: (2018)

Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen
por: Liu, Siwen, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
por: Hu, Yong, et al.
Publicado: (2017)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma
por: Prins, M. J. D., et al.
Publicado: (2012)

Elevated Serum Chloride Levels Contribute to a Poor Prognosis in Patients with IgA Nephropathy
por: Zhai, Yaling, et al.
Publicado: (2021)

Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2015)

High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2023)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
por: Liu, Jia-Si, et al.
Publicado: (2023)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Comparison of nedaplatin-based versus cisplatin-based chemotherapy for advanced non-small cell lung cancer among East Asian populations: A meta-analysis
por: Liu, Yun, et al.
Publicado: (2015)

Association of sirtuin-1 and vascular endothelial growth factor expression with tumor progression and poor prognosis in liposarcoma
por: Wu, Hongzeng, et al.
Publicado: (2020)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
por: Chen, Zhan-hong, et al.
Publicado: (2018)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
por: Xiang, Mengqi, et al.
Publicado: (2023)

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2021)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
por: Qin, Xiaobing, et al.
Publicado: (2017)

Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis
por: Ouyang, Xiwu, et al.
Publicado: (2020)

Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
por: Phan, Thi Le, et al.
Publicado: (2021)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy
por: Fu, Xiang, et al.
Publicado: (2015)

Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
por: Childs, W. J., et al.
Publicado: (1993)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
por: Song, Wenhui, et al.
Publicado: (2016)

Serum vascular endothelial growth factor and cortisol expression to predict prognosis of patients with hypertensive cerebral hemorrhage
por: Zhang, Chao-Yong, et al.
Publicado: (2023)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
por: Zhou, Qiang-Hua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_umi6bo1llone66s1d4hjqfe3lf